ArticleScientific reports2023
Product progression: a machine learning approach to forecasting industrial upgrading.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Article
- Comparative analysis of technological fitness and coherence at different geographical scales.PloS one · 2025Article
- The geography of technological innovation dynamics.Scientific reports · 2023Article
- Quantifying the complexity and similarity of chess openings using online chess community data.Scientific reports · 2023Article
- Urban economic fitness and complexity from patent data.Scientific reports · 2023Article
- Article
- Asymmetric Relatedness from Partial Correlation.Entropy (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Economic complexity methods, and in particular relatedness measures, lack a systematic evaluation and comparison framework. We argue that out-of-sample forecast exercises should play this role, and we compare various machine learning models to set the prediction benchmark. We find that the key object to forecast is the activation of new products, and that tree-based algorithms clearly outperform both the quite strong auto-correlation benchmark and the other supervised algorithms. Interestingly, we find that the best results are obtained in a cross-validation setting, when data about the predicted country was excluded from the training set. Our approach has direct policy implications, providing a quantitative and scientifically tested measure of the feasibility of introducing a new product in a given country.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.